@article{3f3eed7bcd91430096f48dcae08020d9,
title = "Rivaroxaban in patients with a recent acute coronary syndrome",
abstract = "Acute coronary syndromes arise from coronary atherosclerosis with superimposed thrombosis. Since factor Xa plays a central role in thrombosis, the inhibition of factor Xa with low-dose rivaroxaban might improve cardiovascular outcomes in patients with a recent acute coronary syndrome.",
author = "{ATLAS ACS 2–TIMI 51 Investigators} and Mega, {Jessica L} and Eugene Braunwald and Wiviott, {Stephen D} and Jean-Pierre Bassand and Bhatt, {Deepak L} and Christoph Bode and Paul Burton and Marc Cohen and Nancy Cook-Bruns and Fox, {Keith A A} and Shinya Goto and Murphy, {Sabina A} and Plotnikov, {Alexei N} and David Schneider and Xiang Sun and Verheugt, {Freek W A} and Gibson, {C Michael}",
year = "2012",
doi = "10.1056/NEJMoa1112277",
language = "English",
volume = "366",
pages = "9--19",
journal = "New England Journal of Medicine",
issn = "1533-4406",
publisher = "MASSACHUSETTS MEDICAL SOC",
number = "1",
}